AI assistant
Solid Biosciences Inc. — Director's Dealing 2025
Dec 4, 2025
33003_dirs_2025-12-04_765e9417-048e-4606-a3b5-826159a534aa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2025-12-02
Reporting Person: Howton David T (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-02 | Common Stock | M | 13051 | — | Acquired | 37840 | Direct |
| 2025-12-03 | Common Stock | S | 4932 | $5.11 | Disposed | 32908 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-12-02 | Restricted Stock Units | $ | M | 13051 | Disposed | Common Stock (13051) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").
F2: This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Mr. Howton on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Howton.
F3: The RSUs were granted on December 2, 2022 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.